The Fatal Flaws in the “Abortion Pill” Decision
By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.
How Patents Contribute to High Drug Prices
Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.
Promoting Best Practices for U.S. Regulatory Analysis
Benefit-cost analysis experts advocate changes to a draft update of OMB Circular A-4.
New Technology Requires New Regulatory Ambitions
In the face of new technologies, a nonprofit auto safety body provides an institutional model for elevating public protection ambitions.
Does the Constitution Require Agencies to Use Biased Judges?
The Supreme Court should uphold longstanding legislation protecting the neutrality of administrative law judges.
Who Favors Making ALJs At-Will Employees?
An upcoming Supreme Court case highlights why businesses and individuals favor for-cause protection for administrative law judges.
OpenAI Investigation Puts AI Companies on Notice
The FTC’s investigation of ChatGPT may shed light on how consumer protection law applies to artificial intelligence.
Should Big Tech Pay for the Use of Telecom Networks?
EU regulators are considering whether to require major technology firms to pay to use telecom networks.
Regulatory Discretion Fosters Clean Tech
Increased regulatory discretion can improve outcomes for entrepreneurs and enhance the impact of stakeholder activists.
Maintaining the Durability of Regulatory Analysis
Susan Dudley, former OIRA Administrator, discusses proposed changes to federal guidelines for regulatory impact analysis.
Using Technology to Improve Administration
ACUS issues new recommendations to enhance administrative governance through digital technology.
Affirmatively Disclosing Agency Legal Materials
ACUS takes an important step forward toward improving agency disclosure of legal materials.